Sotigalimab Chemische Eigenschaften,Einsatz,Produktion Methoden

Pharmakologie

Sotigalimab binds to CD40 on a variety of immune cell types. This triggers the cellular proliferation and activation of antigen-presenting cells (APCs), and activates B cells, and effector and memory T cells. This results in an enhanced immune response against tumor cells. Sotigalimab also binds to and activates CD40 present on the surfaces of some solid tumor cells, leading to apoptosis and decreased tumor growth.

Sotigalimab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Sotigalimab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific		tp@aladdinsci.com	United States	57505	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8011	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10357	58
Biolab Reagents	027-65279366 18108604356	products@biolabreagent.com	China	9868	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 086-15871494362 13720134139	orders@jknbiochem.com	China	5964	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	400-6206333 1316706386	anhua.mao@aladdin-e.com	China	48459	58
Changsha Fuzhen Biotechnology Co.，LTD	18670069958 18670069958	184792226@qq.com	China	3342	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525	209533805@qq.com	China	9970	58
Wanxin Biotechnology (Jiaxing) Co., LTD	0573-83568680 18057391398	3956524501@qq.com	China	1442	58

---

• Sotigalimab
• Research Grade Sotigalimab(DHD68911)
• Sotigalimab (anti-CD40)
• Research Grade Sotigalimab
• 2305607-45-6